We are live on ! Find out more
PBYI icon

Puma Biotechnology

120 hedge funds and large institutions have $319M invested in Puma Biotechnology in 2021 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 47 increasing their positions, 39 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

62% more call options, than puts

Call options by funds: $1.13M | Put options by funds: $696K

21% more repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 39

15% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 13

2% more funds holding

Funds holding: 118120 (+2)

4.84% less ownership

Funds ownership: 90.97%86.13% (-4.8%)

10% less capital invested

Capital invested by funds: $356M → $319M (-$36.6M)

Holders
120
Holders Change
+2
Holders Change %
+1.69%
% of All Funds
2.09%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
15
Increased
47
Reduced
39
Closed
13
Calls
$1.13M
Puts
$696K
Net Calls
+$430K
Net Calls Change
+$273K
Name Holding Trade Value Shares
Change
Change in
Stake
AC
126
Athanor Capital
New York
-$177K -18,164 Closed
SG Americas Securities
127
SG Americas Securities
New York
-$146K -14,983 Closed
Jane Street
128
Jane Street
New York
-$110K -11,257 Closed
MLICM
129
Metropolitan Life Insurance Company (MetLife)
New York
-$76.7K -7,892 Closed
FC
130
FORA Capital
Florida
-$34K -3,470 Closed
Pacer Advisors
131
Pacer Advisors
Pennsylvania
-$28K -2,837 Closed
MIM
132
MetLife Investment Management
New Jersey
-$23.3K -2,392 Closed
TCOV
133
Trust Company of Vermont
Vermont
-$1K -100 Closed